1-54787800-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001114108.2(TTC22):c.650G>A(p.Gly217Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G217S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001114108.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC22 | NM_001114108.2 | c.650G>A | p.Gly217Asp | missense_variant | Exon 3 of 7 | ENST00000371276.9 | NP_001107580.1 | |
TTC22 | NM_017904.4 | c.650G>A | p.Gly217Asp | missense_variant | Exon 3 of 6 | NP_060374.2 | ||
TTC22 | XM_011541671.3 | c.650G>A | p.Gly217Asp | missense_variant | Exon 3 of 6 | XP_011539973.1 | ||
TTC22 | XM_017001582.2 | c.77G>A | p.Gly26Asp | missense_variant | Exon 3 of 7 | XP_016857071.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000406 AC: 1AN: 246484 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459566Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 725906 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.650G>A (p.G217D) alteration is located in exon 3 (coding exon 3) of the TTC22 gene. This alteration results from a G to A substitution at nucleotide position 650, causing the glycine (G) at amino acid position 217 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at